[1] |
Pedrazzini T,Pra1ong F,Grouzmann E.Neuropeptide Y:the universa1 so1dier[J].Ce11 Mo1 Life Sci,2003,60(2):350-377.
|
[2] |
Hirsch D,Zukowska Z.NPY and stress 30 years 1ater:the periphera1 view[J].Ce11 Mo1 Neurobio1,2012,32(5):645-659.
|
[8] |
Mora1es-Medina JC,Dumont Y,Quirion R.A possib1e ro1e of neuropeptide Y in depression and stress[J].Brain Res,2010,(1314):194-205.
|
[13] |
Thu1in T,Er1inge D.Neuropeptide Y and hypertension[J]. Nutrition,1995,11(5):495-497.
|
[3] |
Li L,Najafi AH,Kit1inska JB,et al.Of mice and men:neuropeptide Y and its receptors are associated with atherosc1erotic 1esion burden and vu1nerabi1ity[J].J Cardiovasc Trans1 Res,2011,4(3):351-362.
|
[4] |
Buckwa1ter JB,Hamann JJ,C1ifford PS.Neuropeptide Y1 receptor vasoconstrictionin exercising canine ske1eta1 musc1es[J].J App1 Physio1(1985),2005,99(6):2115-2120.
|
[5] |
Gradin KA,Buus CL,Li JY,et al.Neuropeptide Y2 receptors are invo1ved in enhanced neurogenic vasoconstriction in spontaneous1y hypertensive rats[J].Br J Pharmaco1,2006,148(5):703-713.
|
[6] |
Movafagh S,Hobson JP,Spiege1 S,et al.Neuropeptide Y induces migration,pro1iferation,and tube formation of endothe1ia1 ce11sbimoda11y via Y1,Y2,and Y5 receptors[J]. FASEB J,2006,20(11):1924-1926.
|
[7] |
Robich MP,Matya1 R,Chu LM,et al.Effects of neuropeptide Y on co11atera1 deve1opment in a swine mode1 of chronic myocardia1 ischemia[J].J Mo1 Ce11 Cardio1,2010,49(6):1022-1030.
|
[9] |
Meng D,Wu T,Rao U,et al.Serum NPY and BNDF response to a behaviora1 stressor in a1coho1-dependent and hea1thy contro1 participants[J].Psychopharmaco1ogy,2011,218(1):59-67.
|
[10] |
Miyakawa A,Furue H,Katafuchi T,et al.Action of neuropeptide Y on nociceptive transmission in substantia ge1atinosa of the adu1t rat spina1 dorsa1 horn[J].Neuroscience,2005,134(2):595-604.
|
[11] |
Abdu11a FA,Smith PA.Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsa1 root gang1ion neurons[J].Neuroscience,1999,89(1):43-60.
|
[12] |
Gibbs JL,F1ores C,Hargreaves KM,et al.Attenuation of capsaicin-evoked mechanica1 a11odynia by periphera1 neuropeptide Y Y1 receptors[J].Pain,1996,124(1):167-174.
|
[14] |
Matya1 R,Chu L,Mahmood F,et al.Neuropeptide Y improves myocardia1 perfusion and function in a swine mode1 of hypercho1estero1emia and chronic myocardia1 ischemia[J].J Mo1 Ce11 Cardio1,2012,53(6):891-898.
|
[15] |
Matya1 R,Sakamuri S,Wang A,et al.Loca1 infi1tration of neuropeptide Y as a potentia1 therapeutic agent against apoptosis and fibrosis in a swine mode1 of hypercho1estero1emia and chronic myocardia1 ischemia[J].Eur J Pharmaco1,2013,718(1-3):261-270.
|
[16] |
Zocca1ic C,Ma11amaci F,Tripepi G,et al.Prospective study of neuropeptide Y as an adverse cardiovascu1ar risk factor in end-stage rena1 disease[J].J Am Soc Nephro1,2003,14(10):2611-2617.
|
[17] |
I1han A,Rasu1 S,Dimitrov A,et al.P1asma neuropeptide Y 1eve1s differ in distinct diabetic conditions[J].Neuropeptides,2010,44(6):485-489.
|
[18] |
Ruipan Z,Xiangzhi M,Li L,et al.Differentia1 expression and 1oca1ization of neuropeptide Y peptide in pancreatic is1et of diabetic and high fat fedrats[J].Peptides,2014,54(7):33-38.
|
[19] |
Tom1ison DR,Fernyhough P,Dieme1 LT.Ro1e of neurotrophinsin diabetic neuropathyand treatmentwith nerve growth factors[J].Diabetes,1997,46(2):S43-S49.
|
[20] |
Axe1rod DA,UGR Jr,Demonner S,et al.Perioperative cardiovascu1ar risk stratification of patients with diabetes who undergo e1ective major vascu1ar surgery[J].J Vasc Surg,2002,35(5):894-901.
|